Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 3 | EJNMMI Radiopharmacy and Chemistry

Fig. 3

From: Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu

Fig. 3

a Serum creatinine (Cr), b Alanine aminotransferase (ALT), c White blood cells (WBC), d Red blood cells (RBC), e Platelets (PLT), and (f) hemoglobin (Hb) in non-tumour bearing NOD/SCID mice at two weeks after i.v. injection (tail vein) of 10.0 MBq (10 μg; ~ 0.07 nmoles) of panitumumab-DOTA-[111In]In, panitumumab-MCP-[111In]In or normal saline, or in NRG mice injected i.v. with 6.0 MBq (10 μg; ~ 0.07 nmoles) of panitumumab-DOTA-[177Lu]Lu. Individual values and mean values (horizontal lines) are shown

Back to article page